APA

Yeh M., Huang C., Huang C., Hsieh M., Hsieh M., Lin Z., Chen S., Huang J., Kuo P., Kuo H., Dai C., Yu M. & Chuang W. (2018). Post-treatment alpha fetoprotein and platelets predict hepatocellular carcinoma development in dual-infected hepatitis B and C patients after eradication of hepatitis C. : Oncotarget.

Chicago

Yeh Ming-Lun, Huang Ching-I, Huang Chung-Feng, Hsieh Meng-Hsuan, Hsieh Ming-Yen, Lin Zu-Yau, Chen Shinn-Cherng, Huang Jee-Fu, Kuo Po-Lin, Kuo Hsing-Tao, Dai Chia-Yen, Yu Ming-Lung and Chuang Wan-Long. 2018. Post-treatment alpha fetoprotein and platelets predict hepatocellular carcinoma development in dual-infected hepatitis B and C patients after eradication of hepatitis C. : Oncotarget.

Harvard

Yeh M., Huang C., Huang C., Hsieh M., Hsieh M., Lin Z., Chen S., Huang J., Kuo P., Kuo H., Dai C., Yu M. and Chuang W. (2018). Post-treatment alpha fetoprotein and platelets predict hepatocellular carcinoma development in dual-infected hepatitis B and C patients after eradication of hepatitis C. : Oncotarget.

MLA

Yeh Ming-Lun, Huang Ching-I, Huang Chung-Feng, Hsieh Meng-Hsuan, Hsieh Ming-Yen, Lin Zu-Yau, Chen Shinn-Cherng, Huang Jee-Fu, Kuo Po-Lin, Kuo Hsing-Tao, Dai Chia-Yen, Yu Ming-Lung and Chuang Wan-Long. Post-treatment alpha fetoprotein and platelets predict hepatocellular carcinoma development in dual-infected hepatitis B and C patients after eradication of hepatitis C. : Oncotarget. 2018.